Rinath Levy-boukris

Title: Rinath Levy-Boukris: Innovator in Macular Edema Treatment

Introduction

Rinath Levy-Boukris is a notable inventor based in Paris, France. He has made significant contributions to the field of ophthalmology, particularly in the treatment of macular edema. His innovative approach addresses a critical issue that affects many individuals suffering from vision loss.

Latest Patents

Rinath Levy-Boukris holds a patent for "Compositions for treating macular edema." This invention focuses on a novel method for treating macular edema, which is a leading cause of vision loss in conditions such as diabetic macular edema, wet age-related macular degeneration (AMD), retinal vein occlusion, and chronic intraocular inflammation. The patent outlines a method that increases the oncotic pressure of the vitreous, facilitating the movement of interstitial water from the retina to reduce or eliminate macular edema. The treatment involves the intravitreal injection of macromolecules that can increase oncotic pressure, including proteins like albumin and gelatin, as well as non-protein macromolecules such as dextran and hydroxyethyl starch.

Career Highlights

Throughout his career, Levy-Boukris has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and Sorbonne Université. His work has been pivotal in advancing the understanding and treatment of macular edema, showcasing his dedication to improving patient outcomes.

Collaborations

Rinath Levy-Boukris has collaborated with notable colleagues, including Francine Behar-Cohen and Raphael Cohen. These partnerships have contributed to the development of innovative solutions in the field of ophthalmology.

Conclusion

Rinath Levy-Boukris is a distinguished inventor whose work in treating macular edema has the potential to transform the lives of many individuals facing vision loss. His innovative approaches and collaborations highlight the importance of research and development in medical science.